A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Cash flow is valuable, but it’s not everything - StockStory helps you identify the companies that truly put it to work. Keeping that in mind, here is one cash-producing company that reinvests wisely to drive long-term success and two best left off your watchlist.
Two Stocks to Sell:
Home Depot (HD)
Trailing 12-Month Free Cash Flow Margin: 8.6%
Founded and headquartered in Atlanta, Georgia, Home Depot (NYSE: HD) is a home improvement retailer that sells everything from tools to building materials to appliances.
Why Is HD Not Exciting?
- Large revenue base makes it harder to increase sales quickly, and its annual revenue growth of 2.3% over the last three years was below our standards for the consumer retail sector
- Poor same-store sales performance over the past two years indicates it’s having trouble bringing new shoppers into its brick-and-mortar locations
- Commoditized inventory, bad unit economics, and high competition are reflected in its low gross margin of 33.2%
At $330.85 per share, Home Depot trades at 21.8x forward P/E. Check out our free in-depth research report to learn more about why HD doesn’t pass our bar.
Diebold Nixdorf (DBD)
Trailing 12-Month Free Cash Flow Margin: 6.6%
With roots dating back to 1859 and a presence in over 100 countries, Diebold Nixdorf (NYSE: DBD) provides automated self-service technology, software, and services that help banks and retailers digitize their customer transactions.
Why Is DBD Risky?
- Sales stagnated over the last five years and signal the need for new growth strategies
- Earnings per share have dipped by 10% annually over the past two years, which is concerning because stock prices follow EPS over the long term
- Low free cash flow margin of -1% for the last five years gives it little breathing room, constraining its ability to self-fund growth or return capital to shareholders
Diebold Nixdorf’s stock price of $88.29 implies a valuation ratio of 14.3x forward P/E. To fully understand why you should be careful with DBD, check out our full research report (it’s free).
One Stock to Buy:
Hims & Hers Health (HIMS)
Trailing 12-Month Free Cash Flow Margin: 2.5%
Originally launched with a focus on stigmatized conditions like hair loss and sexual health, Hims & Hers Health (NYSE: HIMS) operates a consumer-focused telehealth platform that connects patients with healthcare providers for prescriptions and wellness products.
Why Are We Bullish on HIMS?
- Average customer growth of 26.1% over the past two years demonstrates success in acquiring new clients that could increase their spending in the future
- Free cash flow margin jumped by 16.1 percentage points over the last five years, giving the company more resources to pursue growth initiatives, repurchase shares, or pay dividends
- Historical investments are beginning to pay off as its returns on capital are growing
Hims & Hers Health is trading at $32.73 per share, or 2.4x forward price-to-sales. Is now the time to initiate a position? See for yourself in our comprehensive research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.
